<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00630903</url>
  </required_header>
  <id_info>
    <org_study_id>MF99</org_study_id>
    <nct_id>NCT00630903</nct_id>
  </id_info>
  <brief_title>PUVA Versus PUVA + IFN Alpha 2a in Mycosis Fungoides</brief_title>
  <acronym>MF99</acronym>
  <official_title>Prospective, Randomized Multicentic to Compare PUVA+IFN Alpha 2a vs PUVA Alone in Mycosis Fungoides Stages Ia, Ib or IIa.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Madrilenian Group of Cutaneous Lymphomas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Madrilenian Group of Cutaneous Lymphomas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if combination of PUVA with interferon alpha is
      better than PUVA alone to treat mycosis fungoides stage Ia Ib or IIa.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Insufficient accrual
  </why_stopped>
  <start_date>January 2000</start_date>
  <primary_completion_date type="Anticipated">January 2003</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of PUVA vs PUVA + IFN</measure>
    <time_frame>Weeks 4, 8, 12, 16 and 24</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">54</enrollment>
  <condition>Cutaneous T-Cell Lymphoma (Mycosis Fungoides)</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>8-MOP + UVA x 24 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IFN alone, 2 weeks, 8-MOP + UVA irradiation + IFN, 22 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PUVA (8MOP + UVA) + IFN</intervention_name>
    <description>Weeks 3-24: 8.MOP: 0.6 MG/K, 3 times a week, 2 hours pre UVA irradiation (1-2 jul/cm2 according to phototype, increasing until 10 Jul/cm2, if tolerated) IFN: week1: 3, 6 and 9 MU (Mon, Wed, Fry). Weeks 2-24: 9MU 3 times a week)</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PUVA (8-MOP + UVA)</intervention_name>
    <description>Weeks 1-24: 8.MOP: 0.6 MG/K, 3 times a week, 2 hours pre UVA irradiation (1-2 jul/cm2 according to phototype, increasing until 10 Jul/cm2, if tolerated)</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Mycosis fungoides Stage Ia Ib IIa

          -  Written informed consent

          -  18-70 y.o., both sex

          -  No concomitant systemic disease

        Exclusion Criteria:

          -  Pregnant or lactating women

          -  Fertile women not accepting contraception

          -  Medical history of melanoma or non melanoma skin cancer

          -  Concomitant infections

          -  Immunodeficiency states

          -  Previous Heart disease

          -  Respiratory insufficiency

          -  Chronic RRenal insufficiency

          -  Chronic hepatopathy

          -  Epilepsy

          -  Depression

          -  Leucocytes &lt;3000 or neutrophiles &lt;1000 or thrombocytes &lt;100000 or hemoglobin &lt;12 gr/dL
             or ANA &lt;1/80

          -  Treatment with systemic steroids

          -  Altered thyroid hormones

          -  Previous resistance to PUVA and/or IFN

          -  Hypersensitivity to IFN

          -  Patients under treatment with teophiline and/or dicumarol

          -  Previous total skin electron beam

          -  Wash up period less than 3 month for IFN and /or PUVA

          -  Wash up period less than 1 month for topical treatments
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francisco Vanaclocha Sebastián, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital 12 de Octubre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jesús Fernández Herrera, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de la Princesa</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Príncipe de Asturias.</name>
      <address>
        <city>Alcalá de Henares</city>
        <state>Madrid</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Getafe</name>
      <address>
        <city>Getafe</city>
        <state>Madrid</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de la Princess</name>
      <address>
        <city>Madrid</city>
        <zip>28009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fundación Jiménez Díaz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico San Carlos</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Gómez Ulla</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital La Paz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 28, 2008</study_first_submitted>
  <study_first_submitted_qc>March 6, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2008</study_first_posted>
  <last_update_submitted>March 6, 2008</last_update_submitted>
  <last_update_submitted_qc>March 6, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 7, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dr F Vanaclocha Sebastián</name_title>
    <organization>Servicio de Dermatología. Hospital 12 de Octubre</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphoma, T-Cell</mesh_term>
    <mesh_term>Mycoses</mesh_term>
    <mesh_term>Mycosis Fungoides</mesh_term>
    <mesh_term>Lymphoma, T-Cell, Cutaneous</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Interferon-alpha</mesh_term>
    <mesh_term>Methoxsalen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

